Cyclooxygenase-2 polymorphisms confer susceptibility to sarcoidosis but are not related to prognosis

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 427-433

  Lopez Campos, José Luis ^a   Rodriguez Rodriguez, David ^a   Rodriguez Becerra, Eulogio ^a   Alfageme Michavila, Inmaculada ^b   Fernandez Guerra, Jose ^c   García Hernandez, Francisco Javier ^a   Casanova, Alvaro ^d   Fernández de Córdoba Gamero, Javier ^e   Romero Ortiz, Ana ^f   Arellano Orden, Elena ^a   Montes Worboys, Ana ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Cyclooxygenase 2; Genetic polymorphisms; Prognosis; Sarcoidosis

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY;

EID: 59349086089     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.09.014     Document Type: Article

References (24)

1. Statement on sarcoidosis. Am J Respir Crit Care Med 160 (1999) 736-755
2. Agostini C., Meneghin A., and Semenzato G. T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med 8 (2002) 435-440
3. Korn J.H. Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. J Clin Invest 71 (1983) 1240-1246
4. Hempel S.L., Monick M.M., and Hunninghake G.W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93 (1994) 391-396
5. Pang L., Pitt A., Petkova D., and Knox A.J. The COX-1/COX2 balance in asthma. Clin Exp Allergy 28 (1998) 1050-1058
6. Wilborn J., Crofford L.J., Burdick M.D., Kunkel S.L., Strieter R.M., and Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95 (1995) 1861-1868
7. Lama V., Moore B.B., Christensen P., Toews G.B., and Peters-Golden M. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol 27 (2002) 752-758
8. Petkova D.K., Clelland C.A., Ronan J.E., Lewis S., and Knox A.J. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Histopathology 43 (2003) 381-386
9. Hill M.R., Papafili A., Booth H., Lawson P., Hubner M., Beynon H., et al. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 174 (2006) 915-922
10. Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 9 (1992) 211-214
11. Siltzbach L.E., James D.G., Neville E., Turiaf J., Battesti J.P., Sharma O.P., et al. Course and prognosis of sarcoidosis around the world. Am J Med 57 (1974) 847-852
12. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 26 (2005) 948-968
13. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26 (2005) 511-522
14. Macintyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26 (2005) 720-735
15. Skarke C., Schuss P., Kirchhof A., Doehring A., Geisslinger G., and Lötsch J. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Pharmacogenomics 8 (2007) 1643-1660
16. Bernard P.B., and Witter C.T. Homogenous amplification and variant detection by fluorescent hybridization probes by fluorescent hybridization probes. Clin Chem 46 (2000) 147-148
17. Newman L.S., Rose C.S., Bresnitz E.A., Rossman M.D., Barnard J., Frederick M., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
18. Dubaniewicz A., Jamieson S.E., Dubaniewicz-Wybieralska M., Fakiola M., Nancy Miller E., and Blackwell J.M. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet 13 (2005) 829-834
19. Rossman M.D., Thompson B., Frederick M., Maliarik M., Iannuzzi M.C., Rybicki B.A., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 (2003) 720-735
20. Wolter N.J., Kunkel S.L., Lynch III J.P., and Ward P.A. Production of cyclooxygenase products by alveolar macrophages in pulmonary sarcoidosis. Chest 83 (1983) 79S-81S
21. Di Marco S., Hel Z., Lachance C., Furneaux H., and Radzioch D. Polymorphism in the 3′-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res 29 (2001) 863-871
22. Nabors L.B., Gillespie G.Y., Harkins L., and King P.H. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61 (2001) 2154-2161
23. Cipollone F., Toniato E., Martinotti S., Fazia M., Iezzi A., Cuccurullo C., et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 291 (2004) 2221-2228
24. Szczeklik W., Sanak M., and Szczeklik A. Functional effects and gender association of COX2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 114 (2004) 248-253